A randomized, prospective, double-blind clinical trial of the effect of mosapride in patients with small intestinal bacterial overgrowth

Not Applicable

Recruiting

• Conditions: Diseases of the digestive system

• Registration Number: KCT0004994
• Lead Sponsor: The Catholic University of Korea, St. Vincent's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

1) patients of age 20 to 80
2) patients diagnosed with small intestinal bacterial overgrowth in the glucose breath test

Exclusion Criteria

1) Patients who were treated with antibiotics within 3 months
2) Patients diagnosed with gastrointestinal stricture or obstruction at the endoscopy or upper gastrointestinal series
3) Patients with previous gastrointestinal surgery, except for appendectomy
4) Patients who have gastrointestinal bleeding, mechanical obstruction, or perforation
5) Patients who have severe organ dysfunction, such as renal dysfunction or hepatic dysfunction
6) Patients who were treated with medication, such as prokinetics, histamine receptor antagonists, proton pump inhibitors, anticholinergics, antidepressant within 2 weeks before the study
7) Allergic reaction for experimental medicine
8) Improper patient in the study, according to judgement of researcher

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cure rate of small intestinal bacterial overgrowth

Secondary Outcome Measures

Name	Time	Method
Improvement of symptom;The results of glucose breath test